Orchid Of India To Buy U.S.-Based Marketer Karalex To Sell Generics
This article was originally published in PharmAsia News
Executive Summary
India's Orchid Chemicals & Pharmaceuticals says it intends to buy a U.S. marketing company to promote Orchid's generic drugs